Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Everyone's glucose levels fluctuate, but consistently high levels can cause more serious health problems like metabolic disease, insulin resistance and heart disease, Abbott said. The company ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

Blood sugar tracking is officially general-wellness territory. Abbott announced Thursday that ... top dollar for an ...

High blood sugar fluctuations can lead to weight gain, poor sleep, and even long-term health risks like heart disease. That’s where over-the-counter devices, like Abbott’s Lingo, come in ...

Abbott Laboratories and Decom will concentrate on competing in the huge market of potential continuous glucose monitor technology and put any patent disputes behind them for 10 years. North ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to ...

In our view, Abbott's FreeStyle Libre blood glucose monitor franchise is one ... Moreover, some of the high-margin devices also benefit from high switching costs once implanted inside the body ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a ...